Fengyi Precision

The parts Fengyi Precision makes rarely appear in any end product's manual — they are the precision structural components inside medical imaging and semiconductor process tools: housings, drive assemblies, precision chambers, held to micron tolerances. Since building its Suzhou plant in 2004, the company has held to the same core business while its customers upgraded from general-purpose parts to today's high-end equipment market.

Customers are global and regional equipment manufacturers, where procurement sits with engineering and price is never the first consideration — what wins an order is passing qualification and holding consistent quality across years of supply. This gives the company a revenue structure unlike consumer-facing manufacturing: customer concentration runs high, but individual relationships typically last a decade or more.

The founder has served as general manager since the plant was built, and the team is largely longtime employees, with core technical staff averaging more than a decade of tenure. That stability has underpinned quality, but it also means the founder is the central node holding together customer qualifications and accumulated knowledge — precisely what any ownership transition has to address.

The controlling investment in Fengyi Precision was completed in 2016 under the private investments strategy. The transaction was triggered by the founder beginning to consider succession: his children had not entered manufacturing, and while management had operating capability, it lacked equity and final decision authority. The strategy exists for this moment — an established company at a point where succession calls for capital and governance.

Qualification cycles were viewed as the investment's core moat: switching suppliers requires an equipment maker to repeat the full process, often over years, making customers cautious about change. This is what made a controlling position the right structure — deep governance involvement was judged necessary to keep qualifications and knowledge intact after the founder's exit.

Demand for precision structural components in medical imaging and semiconductor equipment persists and tightens as the equipment itself demands more precision, while few machining companies can reliably meet micron-level tolerances. Equipment manufacturers, mindful of quality and compliance risk, generally prefer maintaining existing qualified suppliers, giving companies with an established record a comparatively stable environment.

The localization of semiconductor equipment supply chains has opened new customer sources for domestic machining companies, though qualification standards apply regardless of a supplier's origin — passing remains the only criterion for entry.

Havrion Capital holds a controlling stake in Fengyi Precision, with the board led by the investment team while day-to-day operations remain with original management. The central work has been co-designing a staged handover with the founder: clarifying decision rights for professional managers, building financial reporting and controls, and putting equity incentives in place so core staff stay through the transition.

On customer relationships, the team has helped maintain continuity in existing qualifications through the governance transition, signaling to major customers that a handover would not disrupt supply. Further capital will go toward equipment upgrades and capacity to support growing demand from semiconductor customers.